Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Research Grant, 2020
    Evaluation of ANAVEX2-73 (blarcamesine) in Participants with Parkinson’s Disease

    Study Rationale:    
    We are testing ANAVEX2-73 (also known as blarcamesine), which previous research has shown helps improve behaviors as well as normalizes biochemical changes in a Parkinson’s...

  • , 2020
    The Role of USP30 in Idiopathic Parkinson’s Disease

    Study Rationale:    
    Dopamine neurons are highly vulnerable to age-dependent increases in mitochondrial dysfunction, oxidative stress, and protein accumulation due to their high metabolic activity...

  • Research Grant, 2020
    Biomarker for Mitophagy Pathway Activation

    Study Rationale:    
    Abnormal PINK1-PRKN directed mitochondrial quality control appears to be an important contributor to Parkinson’s disease (PD). Measures to assess activation of this pathway in...

  • Research Grant Supplement, 2020
    Developing Biosignatures for Parkinson's Disease Using Sense of Smell (Supplement)

    Study Rationale:
    It has been described that people with Parkinson’s disease have a specific signature odor. This odor arises from an oily skin secretion called sebum. Odor detection in the nose is...

  • The Role of Inflammation in Parkinson's Disease, 2020
    The Role of Viral Infection in Immune Dysregulation of Cells in Parkinson’s

    Study Rationale:    
    It has been observed that immune cells from Parkinson’s disease (PD) blood respond to pathogens in a way that promotes inflammation. However, it is unknown whether this...

  • Priority Biology, 2020
    Structural Insights into Activated Intermediates of Parkin Continued

    Study Rationale:
    Loss of proteins responsible for removing damaged mitochondria (the cell power plants) is the most common cause of young-onset Parkinson’s disease (YOPD). Parkin and PINK1 are key...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.